buddy, AMARIN has said they will be able to use JELIS (18k patients , 5 years data) in support of SAFETY (yes and nothing more) data for AMR101 and FDA would accept it
for a drug that yielded fantastic results and appears safer than a placebo? doubtful. of course with the fda you never know but i would make bets they won't.